Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 7th November 2022 Vol. No. 11; Issue No. 551

1. Krishnamurthy MN, Pradosh A, Varghese D, Halder S (2022). Clinical pharmacologist from the eyes of a clinical pharmacologist: A questionnaire‑based survey. European Journal of Clinical Pharmacology.

2. Tiwari M, Rauthan A, Chavan P, Subramanian PG, Gujral S, Bhat V (2022). Quality evaluation of sample collection facilities of resource‑limited medical laboratories in various states of India: A comparison between accredited and nonaccredited laboratories. QAI Journal for Healthcare Quality and Patient Safety. 3:8-12

3. Gokarn A, Shenoy R, Punatar S, Mirgh S, Chichra A, Nayak L, Bonda A, Jindal N, Saroha M, Toshniwal A, Prayag P, Tripathi R, Kumar S, Bhat V, Biswas S, Khattry N (2022). Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants. Bone Marrow Transplantation.

4. Kulkarni R, Gupta S (2022). Gynaecological oncology in India: Past, present and future. Indian Journal of Surgical Oncology.

5. Chopra S, Mulani J, Mittal P, Singh M, Shinde A, Gurram L, Scaria L, Dheera A, Kolhe S, Rane P, Ghadi Y, Rath S, Ghosh J, Gulia S, Gupta S, Kinhikar R, Laskar S, Agarwal J (2022). Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic. Brachytherapy.

6. Dhumal S, Patil V, Noronha V, Prabahsh K (2022). Immune checkpoint inhibitors: Promising but still inaccessible treatment option for patients with head-and neck cancer in India. Cancer Research, Statistics, and Treatment. 5(3): 587-588.

7. Patil V, Muthuluri H, Choudhary J, Parekh D, Abraham G, Noronha V, Menon N, Dhumal S, Prabhash K (2022). Nivolumab in platinum-refractory head-and-neck cancers: A retrospective observational audit from a tertiary cancer center. Cancer Research, Statistics, and Treatment. 5:468-73.

8. Kumar S, Shriyan B, Patil A, Yadav S, Jadhav S, Asar M, Krishnamurthy MN, Patil V, Joshi A, Noronha V, Prabhash K, Gota V (2022). Effect of ADME gene polymorphisms on pemetrexed pharmacokinetics in patients with non-small-cell lung cancer: A prospective study. Cancer Research, Statistics, and Treatment. 5: 437-44.

9. Sengar M, Jain H, Shet T, Sridhar E, Gota V, Rangarajan V, Laskar SS, Alahari A, Thorat J, Agarwal A, Sharma N, Gupta H, Kannan S, Kumar S, Nayak L, Menon H, Gujral S, Bagal B (2022). Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas. British Journal of Haematology.

10. Lall S, Bhat V, Biswas S, Joshi A, Janu A (2022). Delftia acidovorans: An unusual pathogen from an adenocarcinoma lung patient with pleural effusion. Journal of Global Infectious Diseases.

Site of the Week

RNAInter provides a comprehensive RNA interactome resource for researchers and paves the way to investigate the regulatory landscape of cellular RNAs.

desktop Image
Interesting Reads

Radwitz J, Hausrat TJ, Heisler FF, Janiesch PC, Pechmann Y, Rübhausen M, Kneussel M. Tubb3 expression levels are sensitive to neuronal activity changes and determine microtubule growth and kinesin-mediated transport. Cell Mol Life Sci. 79(11): 575, 2022.

Legends of Science
Bhalchandra Bhavanishankar Mundkur Bhalchandra Bhavanishankar Mundkur

Bhalchandra Bhavanishankar Mundkur obtained his Ph.D. from the Iowa state college of agriculture, USA, in 1930. His research interest was mycology and plant pathology. He established four genera, over a hundred new species, and new combinations of fungi. The smut genus Mundkurella was named in his honor. He served as Director of the Plant Protection Ministry of Food and Agriculture. A Fellow of the Indian National Science Academy, Dr. Mundkur was a member of the American Phytopathological Society and Founder President of the Indian Phytopathological Society.

Harendra Nath Ray Harendra Nath Ray

Harendra Nath Ray, an eminent parasitologist, received his Ph.D. from the University of London, UK, in 1930. He discovered many new genera and species in Rhizopoda, Mastigophora, Ciliophora, Gregaria, Coccidia, and Haemosphoridia. He was a pioneer in establishing the method of transmission of Thalesemma Annulate in cattle through the eggs of infected ticks. His notable discovery was the presence of small cysts clusters in the liver of the Himalayan flying squirrels depicting the exoerythrocytic schizogony of a malarial parasite referred to as a new genus Rayella. Dr. Ray was President of the Zoology and Entomology Section, Indian Science Congress; and Sectional President Third International Congress of Protozoology, Leningrad. He was also elected Fellow of the Royal School of Tropical Medicine and Hygiene, American Society of Parasitologists, and Zoological Society of India.

Upcoming Events
7th International Inflammatory Breast Cancer Symposium: Understanding and Managing Aggressive Breast Cancer

04-05 December, 2022

At In Person & Virtual at Houston Marriott Medical Center Hotel, Texas.

15th Annual Conference on the Science of Dissemination and Implementation in Health

11-14 December, 2022

At Walter E. Washington Convention Center, Washington, DC.

5th International Conference on Medical Sciences (MEDS 2022)

17-18 December, 2022

At Dubai, UAE.

Do You Know?

The first licenced monoclonal antibody was Orthoclone OKT3 (muromonab-CD3) which was approved in 1986 for use in preventing kidney transplant rejection.

back Image
Cancer News
DNA 'nanotransporters' to treat cancer

02 November 2022, EurekAlert

Using the new drug transporter developed for doxorubicin, the team demonstrated that a specific drug-transporter formulation allows doxorubicin to be maintained in the blood and drastically reduces its diffusion towards key organs such as the heart, lungs and pancreas...

Discovery boosts the potential of new cancer fighting drugs

03 November 2022, MedicalXpress

Scientists at Scripps Research have uncovered a critical feature that a promising new class of cancer drugs, known as CELMoDs, needs to be effective...

Study finds extracellular fluid association with spread of cancer

03 November 2022, ET

Study revealed a unique mechanism that promotes cancer cell spread, as well as providing a foundation for future research that may eventually lead to the discovery of possible new targets to combat cancer metastatis...

� 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)